The Cancer Prevention and Control (CPC) Program is the nexus for population sciences-focused research at Georgetown Lombardi. Its mission is to conduct innovative and impactful population sciences research across the translational continuum, from discovery to intervention to policy, to help alleviate the burden of cancer. A unique aspect of the CPC Program is its capacity to rapidly translate findings through the phases of this continuum within and across each of the Program’s scientific aims.
CPC has 25 full members and 12 associate members who address the cancer prevention-control needs of our catchment area through research focused on cancer risk factors and biomarkers, primary and secondary cancer prevention, and outcomes of cancer treatment and survivorship. Research in the catchment area is facilitated through community-based research sites, including the Capital Breast Care Center and the community-based Office of Minority Health and Health Disparities located in Southeast Washington, DC.
CPC Program members focus on three specific aims:
- Aim 1: Cancer risk factors and biomarkers;
- Aim 2: Primary and secondary cancer prevention;
- Aim 3: Outcomes of cancer treatment and survivorship.
In addition, cross-cutting themes of genetic/genomic underpinnings of cancer risk and response and cancer burdens and disparities are integrated within each of the aims.
- Lucile Adams-Campbell, PhD
- Jan Blancato, PhD
- Simina Boca, PhD
- Dejana Braithwaite, PhD
- Young Chandler, DrPH
- Paula Cupertino, PhD
- Chiranjeev Dash, MBBS, PhD, MPH
- Alejandra Hurtado de Mendoza, PhD
- Radoslav Goldman, PhD
- Lawrence Gostin, JD
- Amanda Graham, PhD
- Kristi Graves, PhD
- David Levy, PhD
- Christopher Loffredo, PhD (Program Leader)
- Jeanne Mandelblatt, MD, MPH
- Darren Mays, PhD, MPH
- Beth N. Peshkin, MS
- Arnold Potosky, PhD
- Habtom Ressom, PhD
- Christine Rini, PhD
- Marc Schwartz, PhD
- Kathryn Taylor, PhD
- Kenneth Tercyak, PhD (Program Leader)
- Judy Wang, PhD
- Yun-Ling Zheng, MD, PhD, MPH